| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Outline of Final Research Achievements |
The goal of this research is to develop simpler and more effective infection prevention system for the prevalence of widespread nosocomial infection and expansion of drug resistant Staphylococcus aureus such as VISA (Methicillin-resistant strain with vancomycin-intermediate resistance) infection.
The main achievements are as follows; 1) Confirming the bactericidal effect and bacteriostatic effect of platinum nanoparticles, 2) Discovering the platinum nanoparticle dispersion has little or no cytotoxicity on conventional cultured human cells, 3) Finding that platinum nanoparticle dispersion does not induce inflammatory cytokine secretion. These results revealed that it is highly possible that protection against infection by platinum nanoparticles can be effective.
|
